Zaynich becomes India's first FDA‑approved antibiotic for dental use

Zaynich, a novel antibiotic developed by Wockhardt, received CDSCO approval on 27 May 2026, preceding its FDA clearance. The drug is now available in India for treating dental infections, providing dentists with a new, potent option for managing resistant bacterial pathogens.